Human Marker Genes and Agents for Diagnosis, Treatment and Prophylaxis of Cardiovascular Disorders and Artherosclerosis
    38.
    发明申请
    Human Marker Genes and Agents for Diagnosis, Treatment and Prophylaxis of Cardiovascular Disorders and Artherosclerosis 审中-公开
    人类基因和诊断,治疗和预防心血管疾病和动脉粥样硬化的代理

    公开(公告)号:US20090214477A1

    公开(公告)日:2009-08-27

    申请号:US11911528

    申请日:2006-04-08

    摘要: The invention relates to novel targets in the screening for compounds useful in the treatment and/or prophylaxis of a disease selected from the group comprising cardiovascular diseases, disorders of lipid metabolism or atherosclerosis. The invention relates to novel compounds for use as a medicament for diseases or conditions involving a disease selected from the group comprising cardiovascular diseases, disorders of lipid metabolism or atherosclerosis. The invention especially relates to antagonists and expression-inhibitory compounds that target G-protein coupled receptors (GPCRs), kinases and proteases, and to methods for identifying such compounds. The invention further relates to methods for identifying these antagonists and expression-inhibitory compounds, and methods for diagnosing a disease selected from the group comprising cardiovascular diseases, disorders of lipid metabolism or atherosclerosis or a susceptibility to such a condition.

    摘要翻译: 本发明涉及筛选用于治疗和/或预防选自包括心血管疾病,脂质代谢紊乱或动脉粥样硬化的疾病的疾病的化合物的新靶标。 本发明涉及用作涉及选自包含心血管疾病,脂质代谢紊乱或动脉粥样硬化的疾病的疾病或病症的药物的新化合物。 本发明特别涉及靶向G蛋白偶联受体(GPCR),激酶和蛋白酶的拮抗剂和表达抑制性化合物,以及用于鉴定这些化合物的方法。 本发明还涉及用于鉴定这些拮抗剂和表达抑制化合物的方法,以及用于诊断选自包含心血管疾病,脂质代谢紊乱或动脉粥样硬化或对这种病症的易感性的疾病的方法。